A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy

Blood cancers generally derive from the bone marrow but there are no current targeted treatments. Here the authors present a bone-marrow-targeting nanoparticle that can bind and pull together tumour and natural killer cells for selective elimination of cancer cells, offering a strategy for the treatment of haematologic cancers.